Baxter Healthcare recall: Dextrose Injection
Baxter Healthcare Corporation is recalling Dextrose Injection – 606 bags. The U.S. Food and Drug Administration published the recall on September 16, 2026; it began on August 17, 2026. Distributed nationwide.
Most serious Class I is the most serious level: a reasonable probability that using or eating the product will cause serious health problems or death.

Share
| Product | Dextrose Injection |
| Brand | Baxter Healthcare |
| Company | Baxter Healthcare Corporation |
| Type | Drugs |
| Classification | Class I |
| Recall date | August 17, 2026 |
| Published by FDA | September 16, 2026 |
| Quantity | 606 bags |
| Recall ID | 99679 |
Recalled products
- Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06
- FDA recall number
- D-0850-2026
- Codes, lots and dates
- Lot #: Y495066, Exp. Date July 31, 2027
- Quantity
- 606 bags
- Classification
- Class I
Identifiers and details
- FDA event ID
- 99679
- Initiated
- Voluntary: Firm initiated
- Status
- Ongoing
- Firm location
- Deerfield, IL, United States
Why it was recalled
The reason the FDA lists: “Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.”
Where it was sold
Nationwide. Distribution as the FDA records it: “U.S. Nationwide.”
What to do
Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.
Official notice: FDA Enforcement Report record (event 99679, openFDA) – the same recall numbers can be searched in the FDA Enforcement Report.
Other Baxter Healthcare recalls
| Date | Recall | Problem | Agency |
|---|---|---|---|
| Sep 30, 2026 | Contamination within the release test equipment flow path could have affected the accuracy… Serious | FDA Class II | |
| Sep 30, 2026 | There is an error in the product description on the Unique Device Identification (UDI) lab… Serious | FDA Class II | |
| Sep 9, 2026 | Presence of particulate matter: Particulates identified as fiberglass Most serious | FDA Class I | |
| Sep 9, 2026 | A software issue that may occur during a Volume/Time (VOT) multi-syringe infusion when a s… Serious | FDA Class II | |
| Sep 9, 2026 | manufacturing-practice violations Serious | FDA Class II | |
| Aug 19, 2026 | Baxter received customer reports of air bubbles in the drip chamber and tubing when a pres… Most serious | FDA Class I | |
| Aug 19, 2026 | Presence of Particulate Matter Most serious | FDA Class I |
All 8 Baxter Healthcare recalls →
About this recall
Is Baxter Healthcare Dextrose Injection recalled?
Yes. Baxter Healthcare Corporation recalled it on August 17, 2026; FDA published it September 16, 2026 (Class I). Only the lots, dates or models listed on this page are included.
Why was it recalled?
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
What should I do if I have it?
Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.
Where was it sold?
Nationwide.
More recalls
Source: recall records published by the U.S. Food and Drug Administration (openFDA Enforcement Reports), the USDA Food Safety and Inspection Service, the Consumer Product Safety Commission and the National Highway Traffic Safety Administration, collected twice a day. Product names, lot codes, dates and model numbers are shown exactly as the agency lists them; the agency's notice is the authority. 77.today is not affiliated with any of these agencies.